Literature DB >> 27325505

CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation.

Laura Hertwig1,2, Isabell Hamann1,2, Silvina Romero-Suarez1,2, Jason M Millward1,2, Rebekka Pietrek1,2, Coralie Chanvillard1,2, Hanna Stuis1,2, Karolin Pollok1,2,3, Richard M Ransohoff4, Astrid E Cardona5, Carmen Infante-Duarte1,2.   

Abstract

Fractalkine receptor (CX3CR1)-deficient mice develop very severe experimental autoimmune encephalomyelitis (EAE), associated with impaired NK cell recruitment into the CNS. Yet, the precise implications of NK cells in autoimmune neuroinflammation remain elusive. Here, we investigated the pattern of NK cell mobilization and the contribution of CX3CR1 to NK cell dynamics in the EAE. We show that in both wild-type and CX3CR1-deficient EAE mice, NK cells are mobilized from the periphery and accumulate in the inflamed CNS. However, in CX3CR1-deficient mice, the infiltrated NK cells displayed an immature phenotype contrasting with the mature infiltrates in WT mice. This shift in the immature/mature CNS ratio contributes to EAE exacerbation in CX3CR1-deficient mice, since transfer of mature WT NK cells prior to immunization exerted a protective effect and normalized the CNS NK cell ratio. Moreover, mature CD11b(+) NK cells show higher degranulation in the presence of autoreactive 2D2 transgenic CD4(+) T cells and kill these autoreactive cells more efficiently than the immature CD11b(-) fraction. Together, these data suggest a protective role of mature NK cells in EAE, possibly through direct modulation of T cells inside the CNS, and demonstrate that mature and immature NK cells are recruited into the CNS by distinct chemotactic signals.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CX3CR1; Chemokines; EAE; NK cells; Neuroinflammation

Mesh:

Substances:

Year:  2016        PMID: 27325505      PMCID: PMC5020316          DOI: 10.1002/eji.201546194

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  60 in total

1.  Evidence for NK cell subsets based on chemokine receptor expression.

Authors:  Robert D Berahovich; Nu L Lai; Zheng Wei; Lewis L Lanier; Thomas J Schall
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

Review 2.  Natural killer cells in human autoimmunity.

Authors:  Malin Flodström-Tullberg; Yenan T Bryceson; Fu-Dong Shi; Petter Höglund; Hans-Gustaf Ljunggren
Journal:  Curr Opin Immunol       Date:  2009-11-04       Impact factor: 7.486

Review 3.  Developmental pathways that generate natural-killer-cell diversity in mice and humans.

Authors:  Nicholas D Huntington; Christian A J Vosshenrich; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2007-09       Impact factor: 53.106

4.  Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis.

Authors:  A Uchida; E M Maida; R Lenzhofer; M Micksche
Journal:  Immunobiology       Date:  1982-02       Impact factor: 3.144

5.  Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.

Authors:  Jenny A Garcia; Paula A Pino; Makiko Mizutani; Sandra M Cardona; Israel F Charo; Richard M Ransohoff; Thomas G Forsthuber; Astrid E Cardona
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

6.  Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta.

Authors:  M Saraste; H Irjala; L Airas
Journal:  Neurol Sci       Date:  2007-06-30       Impact factor: 3.307

7.  The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells.

Authors:  Massimo Vitale; Mariella Della Chiesa; Simona Carlomagno; Chiara Romagnani; Andreas Thiel; Lorenzo Moretta; Alessandro Moretta
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

8.  Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.

Authors:  Johan Mellergård; Måns Edström; Maria C Jenmalm; Charlotte Dahle; Magnus Vrethem; Jan Ernerudh
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

9.  Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells.

Authors:  B Zhang; T Yamamura; T Kondo; M Fujiwara; T Tabira
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

Review 10.  The trafficking of natural killer cells.

Authors:  Claude Grégoire; Lionel Chasson; Carmelo Luci; Elena Tomasello; Frédéric Geissmann; Eric Vivier; Thierry Walzer
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

View more
  20 in total

1.  Regional Distribution of CNS Antigens Differentially Determines T-Cell Mediated Neuroinflammation in a CX3CR1-Dependent Manner.

Authors:  Aditya Rayasam; Julie A Kijak; McKenna Dallmann; Martin Hsu; Nicole Zindl; Anders Lindstedt; Leah Steinmetz; Jeffrey S Harding; Melissa G Harris; Jozsef Karman; Matyas Sandor; Zsuzsanna Fabry
Journal:  J Neurosci       Date:  2018-06-29       Impact factor: 6.167

2.  High-dimensional, single-cell characterization of the brain's immune compartment.

Authors:  Ben Korin; Tamar L Ben-Shaanan; Maya Schiller; Tania Dubovik; Hilla Azulay-Debby; Nadia T Boshnak; Tamar Koren; Asya Rolls
Journal:  Nat Neurosci       Date:  2017-07-24       Impact factor: 24.884

3.  KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.

Authors:  P P Banerjee; L Pang; S S Soldan; S M Miah; A Eisenberg; S Maru; A Waldman; E A Smith; Y Rosenberg-Hasson; D Hirschberg; A Smith; D V Ablashi; K S Campbell; J S Orange
Journal:  Mol Immunol       Date:  2018-11-24       Impact factor: 4.407

4.  Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.

Authors:  Benjamin J Murdock; Tingting Zhou; Samy R Kashlan; Roderick J Little; Stephen A Goutman; Eva L Feldman
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

5.  HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM).

Authors:  Farzaneh Sharifzad; Soura Mardpour; Saeid Mardpour; Esmaeil Fakharian; Adeleh Taghikhani; Amirhossein Sharifzad; Sahar Kiani; Yasaman Heydarian; Marek J Łos; Zahra Azizi; Saeid Ghavami; Amir Ali Hamidieh; Marzieh Ebrahimi
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

6.  CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.

Authors:  Irene Müller; Kathleen Pappritz; Konstantinos Savvatis; Kerstin Puhl; Fengquan Dong; Muhammad El-Shafeey; Nazha Hamdani; Isabell Hamann; Michel Noutsias; Carmen Infante-Duarte; Wolfgang A Linke; Sophie Van Linthout; Carsten Tschöpe
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

7.  TGF-β1 Downregulates the Expression of CX3CR1 by Inducing miR-27a-5p in Primary Human NK Cells.

Authors:  Stefano Regis; Fabio Caliendo; Alessandra Dondero; Beatrice Casu; Filomena Romano; Fabrizio Loiacono; Alessandro Moretta; Cristina Bottino; Roberta Castriconi
Journal:  Front Immunol       Date:  2017-07-25       Impact factor: 7.561

8.  Lung-resident natural killer cells control pulmonary tumor growth in mice.

Authors:  Yutaka Yamamoto; Kiho Miyazato; Kei Takahashi; Naoki Yoshimura; Hideaki Tahara; Yoshihiro Hayakawa
Journal:  Cancer Sci       Date:  2018-07-12       Impact factor: 6.716

9.  Indispensable Role of CX3CR1+ Dendritic Cells in Regulation of Virus-Induced Neuroinflammation Through Rapid Development of Antiviral Immunity in Peripheral Lymphoid Tissues.

Authors:  Jin Young Choi; Jin Hyoung Kim; Ferdaus Mohd Altaf Hossain; Erdenebelig Uyangaa; Seong Ok Park; Bumseok Kim; Koanhoi Kim; Seong Kug Eo
Journal:  Front Immunol       Date:  2019-06-27       Impact factor: 7.561

10.  Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1I249/M280 Variant.

Authors:  Sandra M Cardona; Sangwon V Kim; Kaira A Church; Vanessa O Torres; Ian A Cleary; Andrew S Mendiola; Stephen P Saville; Stephanie S Watowich; Jan Parker-Thornburg; Alejandro Soto-Ospina; Pedronel Araque; Richard M Ransohoff; Astrid E Cardona
Journal:  Front Cell Neurosci       Date:  2018-10-17       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.